Trial intelligence / Profile preview

Neoadjuvant Lazertinib in Resectable EGFR-Mutant Lung Adenocarcinoma Detected by BALF Liquid Biopsy (NeolaBAL)

KCT0007214Phase 2Not yet recruiting

Sponsor

Yuhan

Start

Jun 2022

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1